Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Spyryx Biosciences

Spyryx Biosciences
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Bridge LATEST DEAL TYPE
$10.9M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of therapeutics intended to treat obstructive lung diseases. The company's therapeutics are developed with inhaled peptide for the treatment of orphan lung and respiratory diseases like, Cystic Fibrosis and Chronic Obstructive Pulmonary Disorder.

Formerly Known As
Spyryx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 801-10 Capitola Drive
  • Durham, NC 27713
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Spyryx Biosciences’s full profile, request a free trial.

Spyryx Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Bridge 04-Oct-2018 $10.9M 000.00 Completed Clinical Trials - Phase 2
2. Grant 20-Jun-2017 000 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 24-Apr-2015 $18.2M $18.2M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Spyryx Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Spyryx Biosciences Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Metacrine Venture Capital-Backed San Diego, CA 00 00000 000000000 00000
0000000 Venture Capital-Backed Stevenage, United Kingdom 00 000.00 00000000000 000.00
0000 000000000000 Venture Capital-Backed Austin, TX 0 000.00 00000000000 000.00
000000 Angel-Backed Albuquerque, NM 00000 0000000000 00000
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
To view this company’s complete list of competitors, request access »

Spyryx Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cystic Fibrosis Foundation Corporation 000 0000 000000 0
5AM Ventures Venture Capital Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0

Spyryx Biosciences Executive Team (5)

Name Title Board
Seat
Contact
Info
John Taylor President, Chief Executive Officer & Board Member
Robert Tarran Ph.D Scientific Founder & Board of Director
Timm Crowder Ph.D Senior Vice President of Technical Operations
Alistair Wheeler Chief Medical Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Spyryx Biosciences Board Members (6)

Name Representing Role Since Contact
Info
Andy Jordan Spyryx Biosciences Board Member 000 0000
Brian Daniels MD 5AM Ventures Board Member 000 0000
Christy Shaffer Ph.D Hatteras Venture Partners Board Member 000 0000
John Taylor Spyryx Biosciences President, Chief Executive Officer & Board Member 000 0000
Robert Tarran Ph.D Spyryx Biosciences Scientific Founder & Board of Director 000 0000
You’re viewing 5 of 6 board members. Get the full list »